CCS Integrated Cases

CCS case: well-child visit at 2 months

Clinical Overview and When to Suspect Developmental Concerns at 2 Months

— Confirm appropriate growth (weight, length, head circumference plotted on WHO 0–24 month curves)

— Verify achievement of 2-month developmental milestones

— Administer the 2-month vaccine series

— Screen for postpartum depression in the mother/caregiver (USPSTF Grade B)

— Reinforce anticipatory guidance: safe sleep, feeding, injury prevention

— Weight crossing two major percentile lines downward → failure to thrive workup

— Persistent jaundice beyond 2 weeks → conjugated hyperbilirubinemia workup (biliary atresia must be excluded)

— Absent social smile, no visual tracking, no response to sound

— Lethargy, poor feeding, hypotonia → consider sepsis, metabolic disease, congenital heart disease

— Maternal PHQ-9 ≥10 or Edinburgh Postnatal Depression Scale ≥13

— Sudden Infant Death Syndrome (SIDS) peaks between 2 and 4 months — safe sleep counseling is highest-yield here

— Pertussis incidence is highest in infants <3 months; DTaP at 2 months is the first active protection

— Postpartum depression affects ~10–15% of mothers; under-detection is a known patient safety gap

Step 3 management: Treat the 2-month visit as a bundled preventive encounter — vaccines + developmental surveillance + maternal mental health screen + anticipatory guidance. Missing any one component is the most common board-tested error. On the CCS, order all four explicitly rather than relying on a generic "well-child exam" order.

The 2-month well-child visit is a cornerstone preventive encounter in the Bright Futures/AAP periodicity schedule — it is the first major immunization visit and the first structured developmental check after the newborn period.

Purpose of the visit:

When to suspect a problem (red flags that should redirect the CCS case from routine to focused workup):

Epidemiologic anchors:

Presentation Patterns and Key History

— Breastfed: frequency (8–12 times/day expected), duration, latch issues, maternal nipple pain, vitamin D 400 IU/day supplementation

— Formula-fed: type (iron-fortified), oz per feed (typically 3–4 oz), frequency (q3–4h), proper preparation

— Output: 6+ wet diapers/day, 3–4 stools/day for breastfed, fewer for formula

— Total sleep ~14–17 hours/day, longest stretch 4–6 hours

— Sleep position, surface, location — ask explicitly: back to sleep, firm flat surface, no bed-sharing, no soft bedding, room-sharing recommended

— Social: social smile, makes eye contact, calms when spoken to

— Language: cooing, makes sounds other than crying

— Motor: lifts head 45° in prone, hands beginning to open

— Gestational age, birth weight, nursery course, newborn screen result, hearing screen, CCHD pulse ox screen

— Any ED visits, hospitalizations, antibiotic exposures since discharge

— Smokers in the home, firearms in the home, daycare exposure, water source (well water → nitrate/fluoride consideration)

— Maternal mood — administer Edinburgh Postnatal Depression Scale or PHQ-9

Board pearl: Absence of a social smile by 2 months is the earliest reliably abnormal social milestone and warrants closer surveillance, not immediate referral — recheck at the 4-month visit unless other red flags coexist.

CCS pearl: On the CCS interface, order "history — feeding," "history — sleep/safe sleep," "history — developmental milestones," and "screening — maternal depression" as discrete actions. The simulator credits granular history-taking.

Typical CCS stem: "A 2-month-old former term infant is brought by his mother for a routine well-child visit." Office setting, vitals stable, no acute complaints. Your job is to proactively elicit a structured history even when the parent says "everything is fine."

Feeding history (most informative single domain at 2 months):

Sleep history:

Developmental history (2-month milestones):

Birth and interim history:

Family and social:

Physical Exam Findings and Growth Assessment

— HR 100–160 bpm awake, RR 30–60, T 36.5–37.5°C axillary, SpO₂ ≥97%

— BP not routinely measured in healthy infants <3 years per AAP

— Weight gain ~20–30 g/day in months 1–3; should have regained birth weight by 2 weeks and roughly doubled birth weight by 4–5 months

— Length gain ~3.5 cm/month

— Head circumference gain ~2 cm/month

— Anterior fontanelle: soft, flat, ~2–3 cm; bulging → ↑ICP; sunken → dehydration; early closure <3 months → craniosynostosis workup

— Red reflex bilaterally — absent/white reflex (leukocoria) → urgent ophthalmology for retinoblastoma/congenital cataract

— Hip exam: Barlow and Ortolani — still useful at 2 months; after 3 months, limited abduction and Galeazzi sign predominate. Any positive finding → hip ultrasound

— Cardiac: listen for murmurs — innocent flow murmurs common; harsh, holosystolic, or diastolic murmurs → echo and pediatric cardiology

— Femoral pulses: diminished → coarctation of the aorta

— Abdomen: palpate for masses (Wilms, neuroblastoma rare but possible); umbilical hernia common, reassure

— Genitourinary: confirm bilateral descended testes; undescended at 6 months → urology referral

— Skin: café-au-lait macules (>6 of ≥5 mm → NF1 concern), hemangiomas (PHACE if large facial)

— Neuro: tone (head lag improving), primitive reflexes (Moro, palmar grasp present; should fade by 4–6 months)

Key distinction: A persistent positive Ortolani at 2 months mandates hip ultrasound (not X-ray — ossification is incomplete until ~4–6 months, making radiographs unreliable).

CCS pearl: Order "physical exam — complete" plus targeted "physical exam — hip" and "physical exam — red reflex" to ensure simulator credits these high-yield maneuvers.

Vital signs at 2 months (expected ranges):

Growth parameters — plot on WHO 0–24 month curves (not CDC until age 2):

Head-to-toe exam, high-yield findings:

Screening, Labs, and Routine Studies at 2 Months

— Newborn metabolic screen (state-specific, includes PKU, CH, CAH, CF, hemoglobinopathies, MCAD, SCID, etc.) — review results in chart

— Newborn hearing screen (OAE or ABR) — if not passed, audiology referral by 3 months ("1-3-6 rule": screen by 1 month, diagnose by 3, intervene by 6)

— Critical congenital heart disease (CCHD) pulse oximetry screen at >24 hours of life

— Bilirubin if jaundice noted

— Maternal postpartum depression — EPDS or PHQ-2/9 (USPSTF Grade B)

— Developmental surveillance (formal ASQ-3 not until 9 months, but milestone check now)

— Social determinants screening (food insecurity, housing, intimate partner violence) per AAP

— No CBC (Hgb screen begins at 9–12 months)

— No lead screen (begins at 12 months, earlier if high risk)

— No lipid, no urinalysis, no TSH (unless newborn screen abnormal)

— Persistent jaundice at 2 weeks → total and direct bilirubin (direct >1 mg/dL or >20% of total = pathologic, urgent hepatobiliary workup for biliary atresia — Kasai must be done before 60 days for best outcome)

— Poor weight gain → CBC, CMP, TSH, urinalysis, consider sweat chloride

— Suspected sepsis → CBC, blood culture, urinalysis/culture, LP, CXR; empiric ampicillin + gentamicin or ampicillin + cefotaxime if <28 days, ceftriaxone if 29–60 days

Board pearl: A 2-month-old with persistent jaundice and acholic stools is biliary atresia until proven otherwise — get a direct bilirubin TODAY. Time is liver: Kasai portoenterostomy success drops sharply after 60 days of life.

Universal screening at 2 months is minimal — this is a key Step 3 point. Most labs are NOT routine.

Confirm completion of prior universal screens:

Screens to perform AT the 2-month visit:

Labs not routinely ordered at 2 months:

When to add labs (CCS triggers):

Confirmatory and Targeted Studies When Red Flags Appear

— <4–6 months: hip ultrasound (dynamic Graf method)

— ≥4–6 months: AP pelvis X-ray (ossific nucleus visible)

— Risk factors mandating screening US even with normal exam: breech presentation in 3rd trimester (girls), positive family history (girls)

— Four-extremity blood pressures (coarctation: arm > leg by >20 mmHg)

— Pre- and post-ductal pulse oximetry

— ECG and echocardiogram — order both; pediatric cardiology consult

— CXR if respiratory symptoms or suspected CHF

— Diagnostic ABR by 3 months of age

— Early intervention referral regardless of confirmation pending

— First step: clinical exam; differentiate from positional plagiocephaly (parallelogram-shaped head, ear displaced anteriorly on flattened side, no ridging — managed with repositioning ± helmet)

— If true synostosis suspected: non-contrast head CT with 3D reconstruction or low-dose cranial CT; neurosurgery referral

— Glucose, ammonia, lactate, ABG, urine ketones, urine organic acids, plasma amino acids, acylcarnitine profile

— Recheck newborn screen results

Key distinction: Positional plagiocephaly = soft skull, mobile sutures, "back to sleep" related → repositioning, tummy time, helmet if persistent at 4–6 months. Craniosynostosis = ridged fused suture, restricted growth perpendicular to suture → surgical. Don't order CT for plagiocephaly.

CCS pearl: When ordering an echo on CCS, also place a pediatric cardiology consult in the same time block — parallel processing saves simulator time.

Because routine 2-month visits don't require confirmatory studies, this chunk covers what to order when the visit becomes non-routine.

Suspected developmental dysplasia of the hip (DDH):

Suspected cardiac disease (murmur, cyanosis, poor feeding, diaphoresis with feeds, hepatomegaly):

Suspected hearing loss (failed newborn screen, parental concern):

Suspected craniosynostosis (asymmetric head shape, ridging along suture, restricted fontanelle):

Suspected metabolic disease (lethargy, hypotonia, poor feeding, vomiting):

Immunization Decision Logic at the 2-Month Visit

— DTaP #1 (diphtheria, tetanus, acellular pertussis)

— IPV #1 (inactivated polio)

— Hib #1 (Haemophilus influenzae type b)

— PCV15 or PCV20 #1 (pneumococcal conjugate)

— Hepatitis B #2 (if HepB #1 given at birth; if not, #1 now)

— Rotavirus #1 (oral; RV1 two-dose or RV5 three-dose series)

— Many practices use combination products (e.g., Pentacel = DTaP-IPV-Hib; Pediarix = DTaP-HepB-IPV; Vaxelis = DTaP-IPV-Hib-HepB) to reduce injection burden

— Minimum age for rotavirus first dose: 6 weeks; maximum age for first dose: 14 weeks 6 days; series must be completed by 8 months 0 days — miss the window and the series is forfeited

— Minimum interval between doses 1 and 2 of most primary series: 4 weeks

— Rotavirus: history of intussusception, severe combined immunodeficiency (SCID) → contraindicated

— DTaP: encephalopathy within 7 days of prior dose unrelated to other cause → contraindicated for pertussis component

— Moderate/severe acute illness with fever → defer; mild URI or low-grade fever is NOT a contraindication

— Family history of seizures, SIDS, or adverse vaccine reaction → NOT a contraindication

— Must provide current VIS for each vaccine before administration (federal requirement under National Childhood Vaccine Injury Act)

— Document VIS edition date, vaccine lot, site, route, administering clinician

Step 3 management: A parent asks if a mild runny nose is a reason to delay. Answer: No — proceed with all vaccines. Unnecessary deferral is a missed-opportunity patient safety issue and is heavily tested.

CCS pearl: Order each vaccine as a discrete order, or order the "2-month immunization set." Document VIS provision in the chart note.

At 2 months (minimum age 6 weeks for most), administer the following per CDC/ACIP 2024 schedule:

Timing rules (high-yield):

Contraindications and precautions:

Informed consent and Vaccine Information Statements (VIS):

Pharmacotherapy and Nutritional Supplementation

— All exclusively or partially breastfed infants: 400 IU/day oral vitamin D, starting in the first few days of life and continued until they consume ≥1 L/day of vitamin D-fortified formula or milk

— Formula-fed infants taking <1 L/day also require supplementation

— Deficiency risk: rickets, hypocalcemic seizures

— Term, exclusively breastfed infants: 1 mg/kg/day iron starting at 4 months until iron-rich complementary foods introduced (not yet at 2 months for term infants)

— Preterm infants: 2 mg/kg/day starting at 1 month through 12 months — this DOES apply to a 2-month-old former preterm infant

— Begin at 6 months if water fluoride <0.3 ppm — not at 2 months

— Non-pharmacologic preferred: breastfeeding during/after, sucrose 24% solution (2 mL on tongue 1–2 min before), swaddling, skin-to-skin

— Acetaminophen prophylaxis is NOT recommended — may blunt immune response; use only for documented post-vaccine fever or fussiness (15 mg/kg q4–6h, max 5 doses/24h)

— Ibuprofen contraindicated <6 months

— Honey (botulism risk until 12 months)

— Cow's milk as primary beverage (until 12 months)

— OTC cough/cold preparations (avoid <4–6 years)

— Codeine, tramadol (contraindicated in children)

— Aspirin (Reye syndrome)

Board pearl: A breastfed 2-month-old presenting with a hypocalcemic seizure in winter, dark-skinned mother, no vitamin D supplementation — classic stem for vitamin D deficiency rickets. Always ask about the 400 IU/day supplement at every well-child visit until 12 months.

Step 3 management: Document specific dose, frequency, and duration of vitamin D in the after-visit summary; verbal counseling alone is insufficient for medicolegal documentation.

Vitamin D:

Iron:

Fluoride:

Analgesia for vaccine administration:

Medications to avoid at 2 months:

Probiotics, gripe water, herbal teas: not evidence-based, counsel against

Anticipatory Guidance — The Core "Procedure" of the Visit

— Back to sleep, every sleep, every time

— Firm, flat sleep surface (crib/bassinet meeting CPSC standards)

— Room-sharing without bed-sharing for ≥6 months, ideally 12

— No soft bedding, bumpers, pillows, blankets, stuffed animals

— Pacifier at sleep onset (after breastfeeding established) reduces SIDS risk

— Avoid overheating, avoid smoke exposure

— Breastfeeding is protective

— Continue exclusive breastfeeding or iron-fortified formula until 6 months

— No water, juice, solids, or cereal in the bottle

— Recognize hunger/satiety cues; avoid pressured feeding

— Rear-facing car seat in back seat; never in front of active airbag

— Smoke and CO detectors; set water heater ≤120°F

— Never leave infant unattended on elevated surfaces (rolling soon)

— No walkers (AAP recommends against)

— Tap water for bath only after testing temperature

— Tummy time when awake and supervised, several short sessions/day

— Talk, sing, read to infant daily (Reach Out and Read)

— Limit screen time — none recommended <18–24 months except video chat

— Rectal temp ≥38.0°C (100.4°F) in any infant <3 months → ED for full sepsis evaluation

— Poor feeding, decreased urine output, lethargy, persistent vomiting, difficulty breathing, cyanosis

— Maternal depression screening (addressed above)

— Safe firearm storage (locked, unloaded, ammunition separate)

— Smoking cessation, no smoking in home or car

CCS pearl: On the CCS interface, "advise patient — safe sleep," "advise patient — car seat safety," "advise patient — fever instructions," and "advise patient — return precautions" are individually creditable. Order each.

Anticipatory guidance is the highest-yield Step 3 deliverable at well-child visits. Cover all domains:

Safe sleep (SIDS prevention) — single most life-saving counseling:

Feeding:

Injury prevention:

Development and bonding:

When to call:

Caregiver wellness:

Special Populations — Preterm and Medically Complex Infants

— Corrected age = chronologic age − weeks of prematurity

— Use corrected age for growth plotting and developmental milestones until age 2 (some sources say 3)

— Use chronologic age for immunization timing — no adjustment; vaccines on standard schedule (exception: hepatitis B birth dose deferred in infants <2 kg until 1 month or hospital discharge)

— Preterm infants: 2 mg/kg/day elemental iron from 1 month through 12 months (vs 1 mg/kg/day starting at 4 months for term breastfed infants)

— Nirsevimab (monoclonal antibody) — single dose recommended for all infants <8 months entering their first RSV season; preferred over palivizumab

— Maternal RSVpreF vaccine during pregnancy is an alternative

— Retinopathy of prematurity screening (started in NICU for <30 weeks GA or <1500 g) — confirm follow-up ophthalmology

— Higher risk of sensorineural hearing loss — confirm newborn ABR result and arrange close audiology follow-up

— Acetaminophen dosing weight-based (15 mg/kg/dose); reduce or avoid in hepatic dysfunction

— Aminoglycosides require careful renal dosing — neonatal nomograms differ from infant dosing

— Avoid ceftriaxone in jaundiced or hyperbilirubinemic infants <28 days (displaces bilirubin from albumin) — use cefotaxime

— Higher caloric needs (120–150 kcal/kg/day); may need fortified feeds

— Endocarditis prophylaxis only for specific lesions (unrepaired cyanotic CHD, prosthetic valves, prior IE)

Key distinction: Use corrected age for development and growth, chronologic age for vaccines. Mixing these up is a classic Step 3 distractor.

Board pearl: A 2-month-old former 28-week preemie should have already received nirsevimab (if RSV season) and be on 2 mg/kg/day iron — both commonly missed.

At a 2-month chronologic age visit, a former preterm infant requires modified management:

Corrected (adjusted) age:

Iron supplementation:

RSV prevention:

Eye exam:

Hearing:

Renal/hepatic considerations in 2-month-olds:

Infants with congenital heart disease:

Special Populations — Maternal Conditions and Social Context Affecting the Infant

— Prevalence 10–15%; screen at 1, 2, 4, and 6 month visits (AAP and USPSTF Grade B)

— Tools: Edinburgh Postnatal Depression Scale (EPDS) ≥10 positive screen, ≥13 highly suggestive; PHQ-9 ≥10

— Positive screen → assess for suicidal/infanticidal ideation immediately; if present, urgent psychiatric evaluation and ensure infant safety

— Refer to maternal PCP or OB; consider warm handoff; provide resources (Postpartum Support International, 988)

— Breastfeeding contraindications: active untreated HIV (in US), HTLV, active untreated TB, active herpes lesions on breast, illicit drug use, certain chemotherapy/radioisotopes

— Marijuana: AAP recommends against use during breastfeeding (THC concentrates in breast milk)

— Methadone and buprenorphine: compatible with breastfeeding; encouraged

— Screen privately; mandatory reporting laws vary by state but child abuse is universally mandatory

— Provide hotline (1-800-799-7233)

— Screen with Hunger Vital Sign 2-item tool

— Connect families to WIC, SNAP, food pantries

— Refer to social work, Medical-Legal Partnership if available

— Confirm infant antiretroviral prophylaxis course completed

— HIV DNA/RNA PCR at 14–21 days, 1–2 months, and 4–6 months

— Avoid breastfeeding in US (formula is recommended)

— Confirm HBIG + HepB vaccine at birth; complete series; post-vaccination serology (HBsAg and anti-HBs) at 9–12 months

Step 3 management: A mother screens positive on EPDS with passive thoughts of self-harm but no plan and no thoughts of harming the infant. Action: same-day warm handoff to maternal PCP or behavioral health, safety plan, lethal-means counseling, document; do NOT discharge without a plan.

Maternal postpartum depression:

Maternal substance use:

Intimate partner violence (IPV):

Food insecurity and WIC:

Housing instability, homelessness:

HIV-exposed infant:

Hepatitis B-exposed infant:

Complications and Adverse Outcomes to Anticipate

— Common: local pain/redness/swelling (~25%), low-grade fever (<10%), fussiness, drowsiness — self-limited, manage with cool compress and weight-based acetaminophen if needed

— Uncommon: febrile seizure (more with DTaP-IPV combinations later in infancy)

— Rare: anaphylaxis (~1 per million doses) — observe 15 minutes after vaccination; epinephrine 0.01 mg/kg IM (max 0.3 mg) anterolateral thigh if it occurs

— Rotavirus: intussusception risk slightly elevated in 1–7 days after dose 1 (~1–5 excess cases per 100,000); counsel caregivers on signs (sudden severe abdominal pain episodes, currant jelly stools, palpable mass, lethargy)

— Hypotonic-hyporesponsive episode (HHE) after DTaP: rare, self-limited

— Report serious events to VAERS (Vaccine Adverse Event Reporting System) — federally mandated

— Undetected biliary atresia past 60 days → poor Kasai outcomes, progression to transplant

— Undetected DDH → late presentation with limp, leg length discrepancy, premature OA

— Undetected coarctation → CHF, shock when ductus closes (usually presents earlier but can be subtle)

— Missed hearing loss → speech and language delay; window to intervene by 6 months

— Missed retinoblastoma → mortality and vision loss

— Inadequate safe sleep counseling → SIDS (peaks 2–4 months)

— Inadequate car seat counseling → MVC injury

— Inadequate fever counseling → delayed presentation of serious bacterial infection in <3 months

— Prophylactic acetaminophen blunting vaccine response

— Unnecessary lab work, imaging, antibiotics

Board pearl: Intussusception after rotavirus vaccination most often presents within 1 week of dose 1; the classic triad (pain, currant jelly stools, sausage-shaped mass) is incomplete in many cases — lethargy alone can be the presenting feature. First-line imaging: ultrasound ("target/donut" sign); first-line treatment: air or contrast enema reduction.

Vaccine-related adverse events:

Missed-diagnosis complications:

Anticipatory guidance gaps:

Iatrogenic harm:

When to Escalate — Same-Day Workup, Consult, or Admission

— Full sepsis evaluation considered: CBC with differential, blood culture, urinalysis with culture, inflammatory markers (procalcitonin, CRP), ± LP per AAP 2021 guideline risk stratification

— Empiric antibiotics for ill-appearing or high-risk: ampicillin + ceftazidime/cefepime (28–60 days), or per local protocol

— Admit for observation if labs reassuring but <28 days or ill-appearing

— Lower-risk criteria: >60 days old, GA ≥32 weeks and corrected age ≥45 weeks, first event, duration <1 minute, no CPR by trained provider, no concerning history/exam

— A 2-month-old does NOT meet lower-risk BRUE criteria (age cutoff) → ED, admit for monitoring

— Detailed feeding history, weighed feeds, lactation consult

— Labs as in chunk 4; admit if severe or unsafe home environment

— Bruising in a non-cruising infant ("those who don't cruise rarely bruise"), torn frenulum, retinal hemorrhages, unexplained fracture

— Mandatory CPS report; skeletal survey, head CT/MRI, ophthalmology for retinal exam, social work, child abuse pediatrics consult, admit

— Engage social work, ensure safe caregiver, consider CPS if no safe caregiver

— Pediatric cardiology for pathologic murmur

— Pediatric ophthalmology for absent red reflex (same-day)

— Pediatric surgery for inguinal hernia (within weeks; incarceration is emergent)

— Pediatric urology for hypospadias, undescended testes (later)

CCS pearl: When sending a febrile 2-month-old to the ED from clinic, change CCS location to "Emergency Department" and then begin the sepsis order set; do not waste simulator time ordering inpatient-level labs from the office.

Any infant <3 months with rectal temperature ≥38.0°C (100.4°F) → same-day ED evaluation:

Apparent life-threatening event / Brief Resolved Unexplained Event (BRUE):

Failure to thrive (weight <3rd percentile or crossing 2 major lines):

Concern for non-accidental trauma:

Maternal acute psychiatric emergency with safety concern for infant:

Specialist referrals (non-emergent but same-week):

Key Differentials — Other Routine Pediatric Visits and Common Confusables

— Focus: feeding establishment, weight regain to birth weight, jaundice resolution

— Vaccines: HepB #2 (if not given as part of birth dose schedule)

— No DTaP, IPV, Hib, PCV, rotavirus yet

— First DTaP, IPV, Hib, PCV15/20, rotavirus; HepB #2 (or #1 if delayed)

— Maternal depression screen, safe sleep, social smile expected

— Repeat DTaP #2, IPV #2, Hib #2, PCV #2, rotavirus #2

— Milestones: laughs, rolls front-to-back, holds head steady, reaches for objects

— Begin iron-rich foods at 6 months discussion

— DTaP #3, Hib #3 (depending on product), PCV #3, HepB #3, rotavirus #3 (if RV5), first influenza vaccine in season

— Introduce complementary foods, including peanut-containing products (LEAP trial)

— Begin fluoride if water <0.3 ppm

— No routine vaccines (catch-up only)

— First formal developmental screen (ASQ-3 or PEDS), hemoglobin screen, lead screen if high risk

— MMR, varicella, HepA #1, PCV #4, Hib booster; universal lead and hemoglobin screen

Key distinction: HepB #2 timing: can be given as early as 1 month (4 weeks after #1) or commonly at the 2-month visit as part of combination vaccines. Rotavirus is unique in having a maximum age cutoff for the first dose (14 weeks 6 days) — easily missed if visits are delayed.

Board pearl: The 9-month visit is the first time a formal validated developmental screening tool (ASQ-3) is mandated; before that, surveillance via milestone check is the standard.

Distinguishing the 2-month visit from neighboring visits is high-yield for Step 3 stems that test the periodicity schedule:

1-month visit:

2-month visit (this case):

4-month visit:

6-month visit:

9-month visit:

12-month visit:

15-, 18-, 24-month, then annual visits through adolescence

Key Differentials — Sick Visit Disguised as Well Visit

— Beyond 2 weeks (term) or 3 weeks (preterm) → check fractionated bilirubin

— Direct >1 mg/dL or >20% total → biliary atresia workup (ultrasound, HIDA scan, liver biopsy, pediatric GI/surgery)

— Other causes: breast milk jaundice (unconjugated, well infant, diagnosis of exclusion), hypothyroidism, galactosemia, hemolysis

— Inadequate intake (feeding technique, milk supply, formula prep errors) — most common

— Inadequate absorption (CF, milk protein allergy)

— Increased demand (CHD, hyperthyroidism)

— Psychosocial: neglect

— GERD (frequent, non-bilious, thriving) → reassure, positioning, thicken feeds if severe; PPIs not first-line

— Pyloric stenosis (3–6 weeks classically, but can present at 2 months): projectile non-bilious vomiting, hypochloremic hypokalemic metabolic alkalosis, palpable "olive," ultrasound diagnostic (pyloric muscle ≥3 mm thickness, channel length ≥15 mm)

— Bilious vomiting → malrotation with volvulus — surgical emergency, upper GI study

— Milk protein allergy (blood-streaked stools, eczema) → elemental or extensively hydrolyzed formula trial

— Spinal muscular atrophy (SMA): tongue fasciculations, areflexia, frog-leg posture — SMN1 testing; nusinersen/onasemnogene therapy is time-sensitive

— Congenital hypothyroidism (recheck newborn screen), Prader-Willi, metabolic disease

— CHD, bronchiolitis, pertussis (paroxysmal cough, apnea in young infants — azithromycin treatment and household chemoprophylaxis)

Key distinction: Bilious vomiting in any infant is malrotation with volvulus until proven otherwise — emergent upper GI study, surgical consult. Do not "watch and wait."

Common Step 3 trick: parent brings infant for "well-child visit" but stem contains a buried red flag. Recognize and pivot:

Persistent jaundice:

Poor weight gain:

Vomiting:

Hypotonia:

Cyanosis or respiratory distress:

Discharge Plan, Next Visit, and Long-Term Health Maintenance

— Growth parameters with percentiles

— Developmental milestones reviewed

— Vaccines administered with lot numbers, sites, VIS dates

— Maternal depression screen result and any actions taken

— Anticipatory guidance topics covered

— After-visit summary provided

— Continue vitamin D 400 IU/day if breastfed

— Iron 2 mg/kg/day if preterm

— No routine medications otherwise

— Fever ≥38.0°C rectal → ED immediately

— Poor feeding, decreased wet diapers, lethargy, persistent vomiting, difficulty breathing, cyanosis, seizure

— Persistent crying >2 hours, vaccine site swelling >5 cm, severe vomiting/lethargy within 1 week of rotavirus → call

— Confirm primary care medical home

— WIC enrollment if eligible

— Early Intervention referral if any developmental concern (does not require diagnosis — concern alone is sufficient under IDEA Part C)

— Dental home by age 1 (American Academy of Pediatric Dentistry); discuss now

— Influenza vaccine annually starting at 6 months

— COVID-19 vaccine per current ACIP guidance

— Hemoglobin and lead screening at 9–12 months

— Developmental screen with validated tool at 9, 18, 30 months

— Autism-specific screen at 18 and 24 months (M-CHAT-R/F)

Step 3 management: Always confirm and document the next visit date before the family leaves. No-show rates at 4-month visit are a known quality metric; consider reminder systems (text/portal).

At the end of the 2-month visit, the "discharge plan" (i.e., what leaves the office with the family) includes:

Documented in chart:

Prescriptions / supplements:

Return precautions — explicit handouts:

Next scheduled visit: 4 months for next vaccine series and milestone check

Care coordination:

Long-term preventive plan reminders:

Follow-Up Cadence and Outpatient Handoff

— 4 months: next routine visit, second vaccine series, milestone check (rolls, laughs, head control)

— 6 months: third vaccine series, complementary foods introduction, first flu vaccine in season, fluoride begins if needed

— 9 months: first formal developmental screen, hemoglobin/lead if indicated

— 12 months: MMR/varicella/HepA, universal hemoglobin and lead screen, transition to whole milk discussion, first dental visit

— Caregiver-tracked: feeding pattern, wet diapers, stool pattern, weight gain (home scales optional), milestones

— Office-tracked: growth curves trended at each visit; rate of head circumference growth especially important (microcephaly or macrocephaly trends)

— Family relocating → transfer immunization records via state immunization registry (IIS); provide paper copy

— Insurance change → ensure continuity of medical home; many states have CHIP/Medicaid for transition

— Custody changes → document caregiver of record; both parents have access to records unless court order specifies

— Free evaluation for children 0–3 years with developmental concerns; no diagnosis required

— Parent consent only — pediatrician can refer; eligibility determined by state agency

— IBCLC consultation for ongoing breastfeeding challenges

— Return-to-work pumping plan if mother resuming employment (many mothers return ~12 weeks)

— Pediatric cardiology follow-up timing depends on lesion

— GI for jaundice/FTT typically within 1–2 weeks

— Audiology by 3 months if newborn screen failed

CCS pearl: On case completion, the simulator expects you to schedule the 4-month visit explicitly and provide return precautions. Both are creditable end-of-case actions.

Board pearl: Early Intervention referral does not require physician documentation of a diagnosis — parental or clinician concern about development is sufficient.

Standard follow-up cadence after 2-month visit:

Monitoring parameters between visits:

Handoff scenarios:

Early Intervention (IDEA Part C) referral:

Lactation follow-up:

Outpatient handoff if specialist involved:

Ethical, Legal, and Patient Safety Considerations

— Parents have legal right to refuse in most US jurisdictions (medical, religious, philosophical exemptions vary by state; California, Mississippi, West Virginia, Maine, New York, Connecticut allow only medical)

— Approach: explore concerns, share evidence, motivational interviewing; do not dismiss families on first refusal per AAP, though some practices have dismissal policies (controversial, ethically permitted with adequate notice and bridging care)

— Document refusal with AAP Refusal to Vaccinate form; revisit at each subsequent visit

— Inform of risks (pertussis, measles, etc.) and public health implications

— Vaccine Information Statement (VIS) must be provided before each vaccine administration under the National Childhood Vaccine Injury Act of 1986

— Document VIS edition date and consent

— National Vaccine Injury Compensation Program (VICP) provides no-fault compensation for table injuries — counsel families this exists

— Suspected child abuse or neglect → mandated reporter status; report to CPS even on suspicion (do not need proof)

— Failure to report is itself a legal violation in all 50 states

— Positive postpartum depression screen on the mother in the infant's chart raises privacy questions — document carefully, ideally with maternal consent; some practices document in a separate maternal record

— If suicidal/infanticidal ideation: duty to act overrides confidentiality

— Discharge from hospital nursery → first PCP visit ideally within 3–5 days; missed handoffs are a leading source of missed jaundice and feeding failure

— Communication failures between OB, hospital, PCP are common — verify newborn screen results, hearing screen, bilirubin trajectory, and birth medications (HepB, vitamin K, erythromycin)

— Disparities in vaccine completion, well-child attendance, breastfeeding rates by race/ethnicity and SES — screen for and address social determinants

Step 3 management: A family refuses all vaccines. Action: document discussion, provide VIS and AAP refusal form, schedule follow-up, do not refuse care at first encounter; continue to readdress at every visit.

Vaccine refusal:

Informed consent for vaccines:

Mandatory reporting:

Maternal screening confidentiality:

Transition-of-care safety:

Health equity:

High-Yield Associations and Rapid-Fire Facts

Board pearl: When a stem mentions a 2-month-old, immediately scan for: fever, jaundice, vomiting, hypotonia, murmur, asymmetric hips, abnormal red reflex, or maternal mood — these are the seven hooks that convert a "well visit" into a graded clinical decision.

2 months = first big vaccine visit: DTaP, IPV, Hib, PCV15/20, rotavirus, HepB (#2 typically)

Rotavirus: first dose max age 14 weeks 6 days; series complete by 8 months 0 days; contraindicated with prior intussusception or SCID

Fever ≥38.0°C rectal in <3 months → full sepsis workup

SIDS peaks 2–4 months — safe sleep counseling is highest-yield single intervention

Vitamin D 400 IU/day for all breastfed infants from first days of life

Iron 2 mg/kg/day for preterm infants starting at 1 month; 1 mg/kg/day for term breastfed starting at 4 months

Postpartum depression screen at 1, 2, 4, 6 months — USPSTF Grade B

Social smile by 2 months — earliest social milestone

Red reflex — absence = same-day pediatric ophthalmology (retinoblastoma, cataract)

Hip exam Barlow/Ortolani at every visit until walking; ultrasound for DDH <4–6 months

Femoral pulses — diminished → coarctation

Acetaminophen weight-based dosing; avoid ibuprofen <6 months

No honey until 12 months (botulism)

No cow's milk as primary drink until 12 months

Persistent jaundice >2 weeks → fractionated bilirubin; biliary atresia Kasai before 60 days

Bilious vomiting = malrotation/volvulus until proven otherwise

Bruises in a non-cruising infant = non-accidental trauma until proven otherwise

Nirsevimab for all infants <8 months in first RSV season

Corrected age for development, chronologic age for vaccines, until age 2

Anterior fontanelle closes 9–18 months; bulging = ↑ICP, sunken = dehydration

VAERS for vaccine adverse events; VICP for compensation

Early Intervention (IDEA Part C) — referral on concern, no diagnosis required

Pertussis treatment and prophylaxis: azithromycin

Hand expression and pumping maintain supply; breastfeeding compatible with methadone/buprenorphine

Board Question Stem Patterns

Step 3 management: When you see "2-month-old" in any stem, the answer most often hinges on (1) the right vaccine action, (2) recognition of a buried red flag, or (3) anticipatory guidance specific to the SIDS-risk window.

Pattern 1 — Vaccine logistics: "A 2-month-old presents for a well-child visit. He has a runny nose and temperature of 37.8°C. Which is the next best step?" → Administer all scheduled vaccines (mild illness without fever is not a contraindication).

Pattern 2 — Rotavirus timing: "Mother missed the 2-month visit; infant now 15 weeks old. Which vaccine cannot be given?" → Rotavirus (first dose max 14 weeks 6 days).

Pattern 3 — Safe sleep: "First-time mother asks about sleep positioning." → Back to sleep, firm flat surface, room-share without bed-share, no soft bedding, pacifier may help.

Pattern 4 — Jaundice past 2 weeks: → Fractionated (direct) bilirubin; if direct elevated, urgent workup for biliary atresia.

Pattern 5 — Fever in young infant: "2-month-old with rectal temp 38.4°C." → ED for full sepsis workup, not antipyretics and outpatient observation.

Pattern 6 — Maternal depression: "Mother tearful, EPDS 14." → Assess safety (SI, harm to infant), warm handoff to maternal care, ensure infant safety plan.

Pattern 7 — Hip click: "Positive Ortolani at 2 months." → Hip ultrasound (not X-ray).

Pattern 8 — Absent red reflex: → Same-day pediatric ophthalmology for retinoblastoma/cataract.

Pattern 9 — Preterm management: "Former 30-week infant, chronologic age 2 months." → Corrected age for development; chronologic age for vaccines; iron 2 mg/kg/day; nirsevimab in RSV season.

Pattern 10 — Breastfeeding/supplementation: "Exclusively breastfed infant." → Vitamin D 400 IU/day.

Pattern 11 — Bilious vomiting: → Upper GI study, surgical consult — malrotation/volvulus.

Pattern 12 — Vaccine refusal: → Document, provide VIS and AAP refusal form, do not dismiss on first refusal, revisit at next visit.

Pattern 13 — Intussusception after rotavirus: → Ultrasound first, air/contrast enema reduction.

Pattern 14 — Bruising in non-mobile infant: → Report to CPS, skeletal survey, head imaging, ophthalmology, social work.

Pattern 15 — Prophylactic acetaminophen for vaccines: → Not recommended (may blunt immune response).

One-Line Recap

The 2-month well-child visit bundles the first major vaccine series (DTaP, IPV, Hib, PCV15/20, rotavirus, HepB #2) with structured developmental surveillance (social smile, head control), growth plotting on WHO curves, maternal postpartum depression screening, and anticipatory guidance dominated by safe sleep (SIDS peaks 2–4 months) — while remaining vigilant for buried red flags that convert a routine visit into a focused workup.

Board pearl: Mastery of the 2-month visit = mastery of pediatric preventive care logic — vaccines + milestones + maternal screen + safe sleep + red-flag recognition, every time, in that order.

Vaccines: DTaP, IPV, Hib, PCV15/20, rotavirus (max first-dose age 14w6d), HepB #2 — defer only for moderate/severe illness, not mild URI; no prophylactic acetaminophen.

Surveillance: social smile, coos, lifts head 45° prone, tracks past midline; absent = closer follow-up; red reflex and hip exam at every visit.

Supplements: vitamin D 400 IU/day for all breastfed infants; iron 2 mg/kg/day for preterm infants from 1 month.

Counseling priorities: back to sleep on firm flat surface in own crib, rear-facing car seat, fever ≥38.0°C rectal = ED, no honey, breastfeeding supported, maternal mood screened.

Red flags to pivot on: persistent jaundice (→ direct bilirubin, biliary atresia), bilious vomiting (→ malrotation), positive Ortolani (→ hip US), absent red reflex (→ same-day ophthalmology), bruises in non-cruising infant (→ CPS and abuse workup), fever (→ ED sepsis evaluation), maternal EPDS ≥10 (→ warm handoff, safety plan).

Next steps: schedule 4-month visit, confirm Early Intervention referral threshold (concern alone is sufficient), document VIS provision, provide written return precautions.